PsyBio Therapeutics Presents "How Genetically Modified Bacteria Can Yield Best-In-Class Psychedelics" At The Psychedelic Capital Conference

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Evan Levine, CEO and Chairman of PsyBio Therapeutics Corp PSYB PSYBF, was a guest speaker at Benzinga’s Psychedelic Capital Conference (PCC). 

PsyBio Therapeutics is an intellectual-property-driven biotechnology company developing novel, bespoke, fully approved and psycho-targeted therapeutics to improve mental and neurological health. 

Watch the full interview here. 

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Photo by Michael Schiffer on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny StocksPsychedelicsMarketsBenzinga Psychedelics Capital ConferencePartner ContentPsyBio Therapeutics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...